LifeMD Stock (NASDAQ:LFMD)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$4.97

52W Range

$2.56 - $15.84

50D Avg

$4.39

200D Avg

$4.49

Market Cap

$236.98M

Avg Vol (3M)

$1.09M

Beta

1.99

Div Yield

-

LFMD Company Profile


LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.

Show More

Industry

Medical - Pharmaceuticals

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

304

IPO Date

Jan 29, 2008

Website

LFMD Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 21Dec 20
Product and Services$12.90M--
Work simpli-$445.84K-
Software Revenues, Net--$6.73M
Service Revenues, Net--$5.00K

Fiscal year ends in Dec 25 | Currency in USD

LFMD Financial Summary


Dec 25Dec 24Dec 23
Revenue$194.06M$212.45M$152.55M
Operating Income$-7.67M$-16.14M$-14.49M
Net Income$11.25M$-18.88M$-20.60M
EBITDA$-7.67M$-6.65M$-7.89M
Basic EPS$0.25$-0.53$-0.70
Diluted EPS$0.25$-0.53$-0.70

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 06, 26 | 12:00 AM
Q4 25Mar 09, 26 | 12:00 AM
Q3 25Nov 17, 25 | 4:30 PM

Peer Comparison


TickerCompany
SENSSenseonics Holdings, Inc.
CERSCerus Corporation
OMIOwens & Minor, Inc.
SGHTSight Sciences, Inc.
MASS908 Devices Inc.
TBRGTruBridge, Inc.
TKNOAlpha Teknova, Inc.
SMTISanara MedTech Inc.
HITIHigh Tide Inc.
CVRXCVRx, Inc.